Clinical trials: Bronchopulmonary Cancers, open to volunteers
the Rate of Participation in Screening for PBC
Experimentation With Screening for Bronchopulmonary Cancer and Primary Cardiovascular Prevention, Early Management of COPD and an Offer Exempted From Smoking Cessation
The study consists of recruiting a target population by sending a letter from the Regional Center for Cancer Screening in Ile de France.
- Trial name
- LUMASCAN-2 (NCT05440123)
- Testing
- screening for bronchopulmonary cancer
- Volunteers
- 300 people
- Sponsor
- Centre Hospitalier Intercommunal Creteil
Chronic Lung Disease, Chronic Obstructive Pulmonary Disease
Fitness and Lung Function Among Survivors of Heart Transplant, Leukemia and Infant BPD Through Exercise
This study aims to more accurately assess cardiac function, ventilation and exercise capacity in a non-invasive fashion, and to better characterize exercise intolerance in the setting of three populations of individuals with…
- Conditions
- Chronic Lung Disease, Chronic Obstructive Pulmonary Disease, Acute Lymphoblastic Leukemia, Heart Transplant
- Trial name
- FLASHLITE (NCT05025774)
- Testing
- Physical activity
- Where
- United States
- Volunteers
- 90 people
- Sponsor
- Masonic Cancer Center, University of Minnesota
Non Small Cell Lung Cancer
PEMBRO-K : Evaluation of Pembrolizumab Therapeutic Pharmacological Monitoring Benefit in NSCLC
Solid cancers and their therapeutic management remain a major public health problem due to their increasing prevalence and associated mortality. Among solid cancers, lung cancer ranks 4th among incident cancers.
- Trial name
- PEMBRO-K (NCT06195527)
- Where
- 2 sites in France
- Volunteers
- 75 people
- Sponsor
- University Hospital, Angers
Bronchopulmonary Disease, Diagnoses Disease
Optimizing Bronchopulmonary Cancer Screening
The aim of this study is to evaluate the feasibility of performing a first screening for bronchopulmonary cancer by thoracic scanner in a French cohort within a dedicated, effective and structured network in the pilot centers…
- Trial name
- OPTI-DEPIST (NCT06439901)
- Testing
- Screening, Inclusion, Chest CTscan and follow-up
- Where
- 9 sites in France
- Volunteers
- 500 people
- Sponsor
- Institut Curie